Truist Securities Maintains Buy on Exelixis, Raises Price Target to $38
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained a Buy rating on Exelixis and raised its price target from $33 to $38, indicating a positive outlook for the company's stock.
October 30, 2024 | 3:27 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Truist Securities has maintained a Buy rating on Exelixis and increased the price target from $33 to $38, suggesting confidence in the company's future performance.
The increase in the price target from $33 to $38 by Truist Securities indicates a strong positive sentiment towards Exelixis. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100